Eyedentity Raises $1.5M to Detect Eye Cancer with AI

Eyedentity, a developer of AI-powered eye cancer diagnostic software, has secured €1.3 million ($1.5 million) in its first oversubscribed funding round led by Norrsken Launcher, with participation from Karolinska Institutet Innovation and a group of angel investors.

The  Stockholm-based MedTech startup focuses on the early detection of serious eye diseases through automated analysis of fundus images.

Founded in 2025, Eyedentity is developing AI-enabled software that analyzes fundus images captured during routine eye examinations to identify serious eye diseases. It is already used by eye care professionals.

Digital health startups secured more than $15 billion in VC funding in the 1H (First half) of 2026. The investment activity was led by AI-powered digital health startups. More recently, Flagler Health, a developer of an AI-driven medical practice management system for musculoskeletal (MSK) care providers, has raised a $50 million Series B round, bringing its total funding to $63 million to date.

In another deal, Luminai, a provider of an AI- powered healthcare workflow automation platform, raised $38 million in a Series B funding round, bringing its total funding to date to $60 million.